Rupa Makadia, PhD, MS
Associate Director, Epidemiology Analytics
Janssen Research and Development
Rupa Makadia, PhD, MS is an Associate Director at Janssen Research and Development, a Johnson & Johnson company. Her area of expertise includes epidemiologic analysis of patient populations in various therapeutic areas using observational claims data. She has been leading efforts within Janssen to use observational data for clinical trial feasibility using OHDSI tools. She has been closely involved in converting data into the common data model and conducting epidemiological studies at Janssen. Rupa received her undergraduate degree in Molecular Biology from Cal Poly, San Luis Obispo, her Master of Science in Biostatistics from California State University East Bay, and a PhD in Biomedical Informatics at Rutgers University. Prior to Janssen R&D, Rupa worked in various roles within the health informatics space at Kaiser Permanente and Blue Cross Blue Shield of New Jersey.
Makadia, R, Forlenza J, DeFalco F, Knoll C, Ryan P. Using OHDSI tools to conduct clinical trial feasibility. Poster presented at: OHDSI symposium 2016; 2016 September 23; Washington D.C.
Makadia R, Ryan PB. Transforming the Premier Perspective Hospital Database into the Observational Medical Outcomes Partnership (OMOP) Common Data Model. EGEMS (Wash DC). 2014 Nov 11;2(1):1110. doi: 10.13063/2327-9214.1110. eCollection 2014.
Voss EA, Makadia R, Matcho A, Ma Q, Knoll C, Schuemie M, DeFalco FJ, Londhe A, Zhu V, Ryan PB. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases.J Am Med Inform Assoc. 2015 Feb 10. pii: ocu023. doi: 10.1093/jamia/ocu023. [Epub ahead of print]
Makadia R, Ryan P. Conversion of the Premier Database to the OMOP CDM. Poster presented at: OMOP Symposium; 2013 November 5-6; Washington D.C.
